Positive context积极背景
Stocks股票 / Health Care / INDV
Indivior · Health Care
INDV US listed · USD美股 · 美元
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction.Indivior是一家美国制药公司，最初于1994年作为利洁时集团的分部成立，并于2014年12月从该公司分拆，专注于阿片类药物成瘾的替代产品。
Mid cap中盘 · $4B
Health Care
S&P 600标普600小盘Russell 2000罗素2000
Mixed profile混合特征
$35.82
-$0.18 · -0.50%
52w low52周低 $22.41high高 $42.43
Leader · poor entry — wait for a base领先 · 入场点欠佳 — 等待筑底
Daily low forming, but the bigger trend is still bearish. Small size only; stop below 34.22.日线低点正在形成，但大趋势仍偏空。只适合小仓位；止损设于 34.22 下方。
As of 2026-09-28截至 2026-09-28
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-09-28
Momentum (RSI 14)动量（RSI 14）
50
Neutral zone中性区域
vs 50-day average相对50日均线
-3.8% below下方
Below trend跌破趋势
vs 200-day average相对200日均线
+0.3% above上方
Long trend up长期向上
Volatility波动率
10th percentile第10百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-10-2931
Estimates being raised — 3 analysts预期上调 — 3 位分析师
Beat expectations 4 quarters in a row连续 4 季度超预期
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 46.0%
Valuation估值
Roughly fair vs sector相对行业估值合理| Multiple指标 | INDV | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 21.33x | 29.58 | |
| P/S市销率 | 3.62x | 3.19 | |
| Earnings yield盈利收益率 | 4.69% | 2.56 | |
| FCF yield自由现金流收益率 | -2.08% | 4.11 | |
| Shareholder yield股东收益率 | 0.25% | 1.87 | |
| EV/EBITDA企业价值/EBITDA | 16.93x | 18.26 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
$1.2B2025
20242025
5-yr growth5年复合增速 4.3%
Earnings per share每股收益
$1.642025
20242025
5-yr growth5年复合增速 8100.0%
Free cash flow自由现金流
-$93.0M2025
20242025
Gross margin毛利率
80.2%
Operating margin营业利润率
21.1%
Net margin净利率
16.9%
FCF margin自由现金流利润率
-2.2%
Balance-sheet quality财务体质 3/8
Bankruptcy risk: safe zone破产风险：安全区
Return on equity股本回报率 -214%
Watch关注
Leverage杠杆
Net debt / EBITDA净债务/EBITDA0.46
Current ratio流动比率0.71
Capital allocation资本配置
Buybacks (TTM)回购（TTM）$11.0M
Stock-based comp股权薪酬$26.0M
Debt coming due到期债务
FY2025 10-KIn the 12-month bucket following fiscal period end 2025-12-31, it reported $59.0M due — about 13% of its disclosed principal.在财年期末 2025-12-31 之后12个月的区间内，已披露到期本金为 $59.0M，约占其披露本金的 13%。
All maturity buckets are measured from fiscal period end 2025-12-31, not from today.所有到期区间均从财年期末 2025-12-31 起算，而非从今天起算。
First 12 months after period end报告期末之后首12个月
$59.0M
Year 2第2年
$55.0M
Year 3第3年
$52.0M
Year 4第4年
$50.0M
Year 5第5年
$243.0M
After year 55年以后
$0
Cash reported at 2025-12-31: $195000000.截至 2025-12-31 披露的现金：$195000000。 At the cash-burn pace reported over 2025-01-01 to 2025-12-31, that cash represented about 25.2 months. This scenario excludes debt payments and future financing.按 2025-01-01 至 2025-12-31 期间披露的现金消耗速度，该现金约对应 25.2 个月。此情景不包括债务偿还与未来融资。
Cash reported at 2025-12-31 covers 331% of issuer-reported principal in the 12-month bucket following that fiscal period end.截至 2025-12-31 披露的现金可覆盖该财年期末之后12个月区间内发行人已披露到期本金的 331%。
Cash shortfall against that reported principal: $0相对该已披露本金的现金缺口：$0。
Sources and cash-flow calculation来源与现金流计算
Figures are XBRL facts from one filing — no two years are mixed. Filing数据取自同一份文件中的 XBRL 事实，不跨文件拼接。文件
0001628280-26-012237, period ending报告期截至 2025-12-31, unit单位 USD.
Cache acquired缓存获取时间: 2026-09-26T08:04:10.673358+00:00.
6/6 buckets reported.个区间有披露。
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwoLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThreeLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFourLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
Annual period年度区间 2025-01-01 — 2025-12-31 · USD · 10-K · 0001628280-26-012237 · Filed提交日期 2026-02-26.
Cache acquired缓存获取时间: 2026-09-26T08:04:10.673358+00:00 · Evaluated as of评估截至 2026-09-29.
- Reported operating cash flow已披露经营活动现金流: $-27000000
- Reported equipment spending (capex outflow)已披露设备支出（资本开支流出）: $66000000
- Derived free cash flow (operating cash flow minus capex)计算所得自由现金流（经营现金流减资本开支）: $-93000000
Cash is the reported balance at period end. The runway scenario holds this annual cash-flow pace constant and excludes debt payments, restricted-cash adjustments and future financing.现金为期末已披露余额。现金跑道情景假设本年度现金流速度保持不变，不包括债务偿还、受限现金调整与未来融资。
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
INDV reclaimed its 200-day averageINDV 收复200日均线
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$1.9M net (6 buyers, 2 sellers)-$1.9M 净值（6 买家，2 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Oaktree Capital Management | B | New position新建仓 | 4.4% | 2026-06-30 |
Signal history信号历史
engine events引擎事件
DOWNTREND → UNCONFIRMED TURN下跌趋势 → 未确认转向
HIGH-RISK · NIMBLE ONLY. A daily bottoming setup is forming (swing low in, momentum turned up) — but the higher timeframes haven't confirmed it: the bigger picture is still bearish (weekly momentum negative; investor cycle overdue; last cycle left-translated (topped early)). This is an UNCONFIRMED TURN, not a confirmed buy. Weekly confirmation lags price, so this exact reading covers BOTH bounces that fail AND the first leg of a genuine new cycle — you can't tell which in real time, so treat it as a risk/size signal, not a direction call. Measured: weekly-unconfirmed bottoming setups held the low ~49% of the time vs ~68% once the weekly turns up. The daily cycle has also failed (broke its own start low), which tilts the odds toward failure here. Last cycle was left-translated (topped early) — a bearish structural tell高风险 · 仅限灵活操作。正在形成日线筑底形态（摆动低点已现、动量转向上行）——但更高周期尚未确认：大局仍偏空（周线动量为负；投资者周期已逾期；上一周期左移（见顶偏早））。这是「未确认转向」，并非已确认的买入。周线确认滞后于价格，因此同样的读数既涵盖最终失败的反弹，也涵盖真正新周期的第一段——实时无法判定属于哪一种，故应将其视为风险/仓位信号，而非方向判断。实测：周线未确认的筑底形态约 49% 守住低点，周线转向后升至约 68%。日线周期同样已经失败（跌破其自身起始低点），此处概率更偏向失败。 上一周期为左移结构（见顶偏早）——属于看空的结构性信号
Sep 22, 2026
INDV reclaimed its 200-day averageINDV 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $36.19.收盘重回200日均线 — 经典的多头分界线。$36.19。
Sep 18, 2026
INDV lost its 200-day averageINDV 跌破200日均线
Price closed below the 200-day moving average — the classic bear dividing line. $34.88.收盘跌破200日均线 — 经典的空头分界线。$34.88。
Sep 17, 2026
INDV reclaimed its 200-day averageINDV 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $35.69.收盘重回200日均线 — 经典的多头分界线。$35.69。
Sep 15, 2026
INDV daily MACD crossed upINDV 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $34.22.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$34.22。
Sep 9, 2026
INDV StochRSI turned up from oversoldINDV StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $34.77.StochRSI重回20上方 — 下行动量趋缓的最早预警。$34.77。
Sep 8, 2026
INDV RSI reached oversoldINDV RSI进入超卖
RSI(14) crossed below 30 — washed out; context, not a timing trigger alone. $34.32.RSI(14)下穿30 — 超卖；仅作背景，单独不构成择时。$34.32。
Aug 28, 2026
INDV RSI reached oversoldINDV RSI进入超卖
RSI(14) crossed below 30 — washed out; context, not a timing trigger alone. $34.87.RSI(14)下穿30 — 超卖；仅作背景，单独不构成择时。$34.87。
Showing the last 15 of显示最近15条，共 241 signals条信号
Company profile公司档案
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction.Indivior是一家美国制药公司，最初于1994年作为利洁时集团的分部成立，并于2014年12月从该公司分拆，专注于阿片类药物成瘾的替代产品。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Profitability盈利能力
Above market高于市场
Quality质量
Below market低于市场
Investment资本投入
Above market高于市场
Shareholder payout股东回报
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Above market高于市场
Short interest空头兴趣
Below market低于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
- Margin compression despite revenue growth
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（静态） | 21.3× | 29.6× | 73% |
| Price / Sales市销率 | 3.6× | 3.2× | 40% |
| EV / EBITDAEV/EBITDA | 16.9× | 18.3× | 58% |
| Earnings yield盈利收益率 | 4.7% | 2.6% | 80% |
| Free-cash-flow yield自由现金流收益率 | -0.6% | 5.5% | 7% |
| Shareholder yield股东综合回报率 | 0.2% | 1.9% | 17% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
77/100 — stronger than most强于多数
vs market, 3 months相对大盘（3个月）
23/100 — weaker than most弱于多数
vs market, 6 months相对大盘（6个月）
69/100 — middle of the pack居中
vs market, 12 months相对大盘（12个月）
84/100 — stronger than most强于多数
Rank in sector行业内排名
#55 / 173
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +2.7% | +1.3% |
| 1 Month近1月 | +-0.0% | +0.9% |
| 3 Months近3月 | -14.4% | +6.1% |
| 6 Months近6月 | +23.6% | +22.3% |
| Year to date年初至今 | +0.3% | +13.8% |
| 1 Year近1年 | +57.0% | +18.5% |
| 3 Years近3年 | +66.2% | +87.8% |
Trading information交易信息
Beta vs market贝塔
0.46
Volatility rank波动率分位
10th pctile
Short interest空头占比
8.9% of float
Market cap市值
$4B
EPS (trailing)每股收益
$1.68
Off 52-week high距52周高点
-14.4%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20242024 | 20252025 | |
|---|---|---|
| Revenue营业收入 | $1.2B | $1.2B |
| EPS每股收益 | $0.02 | $1.64 |
| Free cash flow自由现金流 | $7M | $-93M |
| Gross margin毛利率 | 80.6% | 80.2% |
| Net margin净利率 | 0.2% | 16.9% |
| FCF margin自由现金流利润率 | 0.6% | -7.5% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$1.2B
Gross profit毛利润
$994M
Net income净利润
$210M
Operating cash flow经营现金流
$-27M
Total assets总资产
$1.2B
Shareholder equity股东权益
$-98M
Long-term debt长期负债
$290M
Buybacks股票回购
$11M
Shares outstanding总股本
0.13B
Returns & growth回报与增长
Return on equity股本回报率
-214.3%
Return on assets资产回报率
17.5%
Debt / assets负债/资产
24.1%
Profit growth利润增速
+2900.0%
Asset growth资产增速
-8.7%
Accounting quality checks会计质量检查
- Earnings quality: accruals elevated vs peers (earnings lean on non-cash items)盈利质量：应计利润高于同业（盈利依赖非现金项目）
- Pricing power: strong gross profitability vs peers定价能力：毛利能力强于同业
- Capital discipline: investment near the peer median资本纪律：投资力度接近同业中位
- Balance sheet: Altman Z 3.27 — safe zone资产负债表：Altman Z 3.27——安全区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
50
RSI (2-day)RSI（2日）
41
vs 20-day average相对20日均线
+2.3%
vs 50-day average相对50日均线
-3.8%
vs 200-day average相对200日均线
+0.3%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
above signal位于信号线上方
Timeframe alignment多周期共振
Daily日线
momentum up动能向上
3-day3日线
momentum down — turning up soon动能向下——接近转强
Weekly周线
momentum down动能向下
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range state波幅状态
CoiledCOILED
Days compressed已压缩天数
7
Range width percentile波幅宽度分位
9/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $1.15 | $0.97 | +18.6% |
| Mar 2026 | $0.96 | $0.64 | +50.0% |
| Dec 2025 | $0.82 | $0.65 | +26.1% |
| Sep 2025 | $0.72 | $0.38 | +89.5% |
Estimate revisions预期修正
Analysts covering覆盖分析师
3
Estimate direction预期调整方向
mostly raising多数上调
Estimate change, 90 days预期变化（90天）
+24.6%
Net upgrades, 30 days净上调（30天）
+3
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Oaktree Capital Management | B | New position新建仓 | 4.4% | $258M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
1
Buying vs selling买入vs卖出
1 : 0
Quarterly trend季度趋势
{'direction': 'accumulating', 'n_quarters': 10, 'holders_first': 1, 'holders_last': 1, 'holders_delta': 0, 'value_change_pct': 250.6, 'from_period': '2024-03-31', 'to_period': '2026-06-30', 'available_on': '2026-08-14', 'available_on_first': '2024-05-14', 'holders_series': [1, 1, 1, 1, 1, 1, 2, 2, 1, 1]}{'direction': 'accumulating', 'n_quarters': 10, 'holders_first': 1, 'holders_last': 1, 'holders_delta': 0, 'value_change_pct': 250.6, 'from_period': '2024-03-31', 'to_period': '2026-06-30', 'available_on': '2026-08-14', 'available_on_first': '2024-05-14', 'holders_series': [1, 1, 1, 1, 1, 1, 2, 2, 1, 1]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$1.9M
Insider buyers vs sellers内部人买家vs卖家
6 : 2
Short interest空头占流通盘
8.9%
Days to cover回补天数
5.7
Short interest change空头变化
-1.1%
Recent fund flows近期基金流向
SPDR S&P PharmaceuticalsSPDR S&P Pharmaceuticals
accumulating持续增持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Seasonality — full detail季节性 — 完整明细
Strongest month最强月份
Mar · 67%
Weakest month最弱月份
Aug · 25%
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 33% | -1.2% | 3 |
| Feb2月 | 33% | -7.6% | 3 |
| Mar3月 | 67% | +0.8% | 3 |
| Apr4月 | 67% | +19.8% | 3 |
| May5月 | 67% | +4.7% | 3 |
| Jun6月 | 67% | +13.6% | 3 |
| Jul7月 | 33% | -2.2% | 3 |
| Aug8月 | 25% | -3.4% | 4 |
| Sep9月 | 50% | +2.7% | 4 |
| Oct10月 | 33% | -5.2% | 3 |
| Nov11月 | 67% | +14.0% | 3 |
| Dec12月 | 67% | +6.8% | 3 |
History is a tendency, not a promise — small samples wobble.历史规律只是倾向而非保证 — 样本少时波动大。
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。